The Cooper Companies, Inc. $COO Shares Sold by Asset Management One Co. Ltd.

Asset Management One Co. Ltd. decreased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 8.0% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 81,236 shares of the medical device company’s stock after selling 7,077 shares during the period. Asset Management One Co. Ltd.’s holdings in Cooper Companies were worth $5,570,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. J.Safra Asset Management Corp lifted its stake in Cooper Companies by 204.8% during the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after purchasing an additional 340 shares during the last quarter. CYBER HORNET ETFs LLC bought a new position in shares of Cooper Companies in the second quarter valued at $36,000. MUFG Securities EMEA plc acquired a new stake in shares of Cooper Companies during the 2nd quarter valued at $42,000. Assetmark Inc. boosted its stake in shares of Cooper Companies by 357.8% during the 2nd quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock worth $44,000 after acquiring an additional 483 shares in the last quarter. Finally, Mather Group LLC. bought a new stake in shares of Cooper Companies during the 3rd quarter worth $56,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently commented on COO. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a report on Friday, December 5th. Barclays reaffirmed an “overweight” rating and set a $91.00 price objective on shares of Cooper Companies in a research note on Monday, December 8th. Robert W. Baird lifted their target price on shares of Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a research report on Friday, December 5th. Piper Sandler restated an “overweight” rating and issued a $94.00 price target (up previously from $83.00) on shares of Cooper Companies in a research report on Friday, December 5th. Finally, Citigroup reaffirmed a “neutral” rating and issued a $88.00 price objective (up previously from $72.00) on shares of Cooper Companies in a research note on Monday, December 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Cooper Companies has a consensus rating of “Moderate Buy” and an average price target of $90.15.

Insider Buying and Selling at Cooper Companies

In other news, insider Holly R. Sheffield purchased 1,230 shares of the stock in a transaction that occurred on Tuesday, December 16th. The stock was acquired at an average price of $80.75 per share, with a total value of $99,322.50. Following the purchase, the insider owned 39,052 shares in the company, valued at $3,153,449. This represents a 3.25% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Maria Rivas acquired 1,000 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The stock was purchased at an average price of $82.13 per share, for a total transaction of $82,130.00. Following the acquisition, the director directly owned 11,141 shares of the company’s stock, valued at $915,010.33. The trade was a 9.86% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 16,014 shares of company stock worth $1,304,416 over the last quarter. Insiders own 1.98% of the company’s stock.

Cooper Companies Trading Down 0.9%

NASDAQ COO opened at $83.13 on Friday. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 1-year low of $61.78 and a 1-year high of $100.24. The firm’s fifty day simple moving average is $77.66 and its 200-day simple moving average is $73.21. The company has a market capitalization of $16.29 billion, a PE ratio of 44.22, a price-to-earnings-growth ratio of 2.40 and a beta of 1.03.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the previous year, the company posted $1.04 earnings per share. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its board has initiated a stock repurchase plan on Wednesday, September 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical device company to reacquire up to 15.4% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s management believes its shares are undervalued.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.